inflammatix.com Open in urlscan Pro
198.71.233.231  Public Scan

Form analysis
1 forms found in the DOM

GET https://inflammatix.com/

<form role="search" class="searchform fusion-search-form  fusion-live-search fusion-search-form-classic" method="get" action="https://inflammatix.com/">
  <div class="fusion-search-form-content">
    <div class="fusion-search-field search-field">
      <label><span class="screen-reader-text">Search for:</span>
        <input type="search" class="s fusion-live-search-input" name="s" id="fusion-live-search-input-0" autocomplete="off" placeholder="Search..." required="" aria-required="true" aria-label="Search...">
      </label>
    </div>
    <div class="fusion-search-button search-button">
      <input type="submit" class="fusion-search-submit searchsubmit" aria-label="Search" value="" data-color="rgb(255, 255, 255)">
      <div class="fusion-slider-loading"></div>
    </div>
  </div>
  <div class="fusion-search-results-wrapper">
    <div class="fusion-search-results"></div>
  </div>
</form>

Text Content

Product in development, is not for sale, and does not have marketing approval or
clearance from regulatory authorities in any jurisdiction.

of acute infections

PRESENCE

TYPE

SEVERITY

Quickly identifies the

TriVerity™

Product in development, is not for sale, and does not have marketing approval or
clearance from regulatory authorities in any jurisdiction.

BACTERIAL

or

VIRAL

Quickly identifies
infections as

BacVerity™

Skip to content
 * Pipeline
   * TriVerity
   * BacVerity
   * Our Approach
   * In Development
 * Education
   * Inflammatix Topix
   * Inflammatix Didactix
   * Advocacy
 * Evidence
   * Publications
   * Abstracts
 * Groundbreaking Science
   * Machine Learning
 * News
   * Press Releases
   * Inflammatix in the News
   * Media Contact
   * Logos
   * Events
 * Careers
 * About
   * Our Mission
   * Leadership
   * Investors
   * Partner With Us
   * Awards
   * Contact Us
 * Ask a Question
 * Search for:
   
   


 * Pipeline
   * TriVerity
   * BacVerity
   * Our Approach
   * In Development
 * Education
   * Inflammatix Topix
   * Inflammatix Didactix
   * Advocacy
 * Evidence
   * Publications
   * Abstracts
 * Groundbreaking Science
   * Machine Learning
 * News
   * Press Releases
   * Inflammatix in the News
   * Media Contact
   * Logos
   * Events
 * Careers
 * About
   * Our Mission
   * Leadership
   * Investors
   * Partner With Us
   * Awards
   * Contact Us
 * Ask a Question



We’re reimagining diagnostics by

READING THE IMMUNE SYSTEM





Inflammatix – Homebiosearchadmin2022-08-12T14:32:30-07:00

We’re reimagining diagnostics by

READING THE IMMUNE SYSTEM

HOST RESPONSE DIAGNOSTICS

Delivering precision medicine on demand






ACTIONABLE RESULTS



We rapidly measure the patient’s immune response using proprietary algorithms to
generate clinically actionable results in less than 30 minutes. Faster diagnosis
means smarter antibiotics prescribing and level of care decisions, which enables
better patient outcomes.


CLINICALLY VALIDATED



Validated in numerous independent cohorts involving thousands of patients and
published in leading medical journals, Inflammatix is your trusted partner for
providing state-of-the-art diagnostic solutions.



SEE OUR PIPELINE




Product in development, is not for sale, and does not have marketing approval or
clearance from regulatory authorities in any jurisdiction.




ACUTE INFECTION & SEPSIS TEST FOR HOSPITALS



Determine the presence, type and severity of infection to make smarter
antibiotic prescribing and admission decisions.


Learn More



Product in development, is not for sale, and does not have marketing approval or
clearance from regulatory authorities in any jurisdiction.




ACUTE INFECTION TEST FOR CLINICS



Quickly determine whether infections are likely viral or bacterial to empower
appropriate antibiotic usage.


Learn More



Product in development, is not for sale, and does not have marketing approval or
clearance from regulatory authorities in any jurisdiction.

Our tests are addressing significant clinical needs in acute infection and
sepsis diagnosis that affect millions of people

Products in development, not for sale, and do not have marketing approval or
clearance from regulatory authorities in any jurisdiction.




IN THE NEWS

Recent notable news stories



Do Your Genes Know What’s Making You Sick?

January 6, 2022



Artificial Intelligence for Clinical Decision Support in Sepsis

May 13, 2021



Inflammatix Checks off All the Right Boxes with Investors

March 19, 2021



Inflammatix nets $102M to advance its immune system tests for infectious
diseases

March 16, 2021




Also covered by

 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 

SEE ALL NEWS


Stay in touch with social updates:
Find out the latest news.


Follow us on Twitter

Follow us on LinkedIn


Inflammatix is reimagining diagnostics by developing rapid tests that read the
immune system to resolve major clinical and public health challenges. Our
initial focus is on acute bacterial and viral infections, and sepsis.



We’re seeking teammates with expertise, curiosity and passion for solving
clinical challenges with a focus on patient outcomes. If that sounds like you,
check out our Careers Page.




© Copyright 2022, Inflammatix, Inc.     All Rights Reserved   |   Terms &
Conditions   |   Privacy & Cookies Statement
Products in development, are not for sale, and do not have marketing approval or
clearance from regulatory authorities in any jurisdiction.
LinkedInTwitter




Page load link

Go to Top
Cookies Button


COOKIE SETTINGS

By clicking “Accept All Cookies”, you agree to the storing of cookies on your
device to enhance site navigation, analyze site usage, and assist in our
marketing efforts. Privacy & Cookies Statement

Accept All Cookies
Reject All
Cookies Settings